These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 34120772

  • 1. A novel 5'ALK fusion identified by next generation sequencing and validated by IHC in a patient with lung adenocarcinoma.
    He Z, Zhu X, Zeng Q, Yu Z.
    Lung Cancer; 2021 Aug; 158():164-165. PubMed ID: 34120772
    [No Abstract] [Full Text] [Related]

  • 2. PLB1-ALK: A novel head-to-head fusion gene identified by next-generation sequencing in a lung adenocarcinoma patient.
    Wang B, Chen R, Wang C, Chen H, Zhong D.
    Lung Cancer; 2021 Mar; 153():176-178. PubMed ID: 33483162
    [No Abstract] [Full Text] [Related]

  • 3. Next-generation Sequencing Identified a Novel WDPCP-ALK Fusion Sensitive to Crizotinib in Lung Adenocarcinoma.
    He Z, Wu X, Ma S, Zhang C, Zhang Z, Wang S, Yu S, Wang Q.
    Clin Lung Cancer; 2019 Sep; 20(5):e548-e551. PubMed ID: 31281052
    [No Abstract] [Full Text] [Related]

  • 4. SRBD1-ALK, a Novel ALK Fusion Gene Identified in an Adenocarcinoma Patient by Next-Generation Sequencing.
    Hou X, Xu H, Chen L.
    J Thorac Oncol; 2019 Apr; 14(4):e72-e73. PubMed ID: 30922581
    [No Abstract] [Full Text] [Related]

  • 5. PARD3-ALK: A novel ALK fusion gene identified in a patient with lung adenocarcinoma.
    Yang L, Zhao W, Zhu H, Li X, Zhao G.
    Lung Cancer; 2021 Apr; 154():219-220. PubMed ID: 33676770
    [No Abstract] [Full Text] [Related]

  • 6. An intergenic region ALK fusion identified by DNA sequencing and validated by IHC in an early-stage lung adenocarcinoma.
    Dou Y, Duan Q, Qi C, Hou L, Wang H.
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1865-1867. PubMed ID: 33544200
    [Abstract] [Full Text] [Related]

  • 7. SMPD3-ALK: A novel ALK fusion gene in lung adenocarcinoma.
    Liang Y, Wang Y, Wang W, Zhao J, Xu M, Zheng M.
    Clin Genet; 2021 Mar; 99(3):488-489. PubMed ID: 33556194
    [Abstract] [Full Text] [Related]

  • 8. Identification and Development of a Lung Adenocarcinoma PDX Model With STRN-ALK Fusion.
    Ren H, Hou X, Eiken PW, Zhang J, Pierson KE, Nair AA, Davila JI, Kovarikova H, Jang JS, Johnson SH, Molina JR, Marks RS, Yang P, Yi JE, Mansfield AS, Jen J.
    Clin Lung Cancer; 2019 Mar; 20(2):e142-e147. PubMed ID: 30581091
    [No Abstract] [Full Text] [Related]

  • 9. DNA and RNA sequencing revealed a complex intergenic-ALK fusion in a lung adenocarcinoma patient who responded to TKI therapy.
    Zhang J, Huang J, Li Q, Lin H, Luo Z, Chen R.
    Lung Cancer; 2021 Sep; 159():171-174. PubMed ID: 34266695
    [No Abstract] [Full Text] [Related]

  • 10. Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches.
    Vendrell JA, Taviaux S, Béganton B, Godreuil S, Audran P, Grand D, Clermont E, Serre I, Szablewski V, Coopman P, Mazières J, Costes V, Pujol JL, Brousset P, Rouquette I, Solassol J.
    Sci Rep; 2017 Oct 02; 7(1):12510. PubMed ID: 28970558
    [Abstract] [Full Text] [Related]

  • 11. The clinical responses of TNIP2-ALK fusion variants to crizotinib in ALK-rearranged lung adenocarcinoma.
    Feng T, Chen Z, Gu J, Wang Y, Zhang J, Min L.
    Lung Cancer; 2019 Nov 02; 137():19-22. PubMed ID: 31521978
    [Abstract] [Full Text] [Related]

  • 12. Identification of a novel crizotinib-sensitive MET-ATXN7L1 gene fusion variant in lung adenocarcinoma by next generation sequencing.
    Zhu YC, Wang WX, Xu CW, Zhang QX, Du KQ, Chen G, Lv TF, Song Y.
    Ann Oncol; 2018 Dec 01; 29(12):2392-2393. PubMed ID: 30339198
    [No Abstract] [Full Text] [Related]

  • 13. Coexistence of a Novel PRKCB-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient and Response to Crizotinib.
    Luo J, Gu D, Lu H, Liu S, Kong J.
    J Thorac Oncol; 2019 Dec 01; 14(12):e266-e268. PubMed ID: 31757376
    [No Abstract] [Full Text] [Related]

  • 14. Next generation sequencing detection in archival surgically resected lung adenocarcinoma specimens harbouring the anaplastic lymphoma kinase fusion protein.
    Jiang Z, Li C, Lu H.
    J Pak Med Assoc; 2021 Feb 01; 71(2(A)):531-536. PubMed ID: 33819244
    [Abstract] [Full Text] [Related]

  • 15. Concomitant EGFR Mutation and EML4-ALK Rearrangement in Lung Adenocarcinoma Is More Frequent in Multifocal Lesions.
    Fan J, Dai X, Wang Z, Huang B, Shi H, Luo D, Zhang J, Cai W, Nie X, Hirsch FR.
    Clin Lung Cancer; 2019 Jul 01; 20(4):e517-e530. PubMed ID: 31138506
    [Abstract] [Full Text] [Related]

  • 16. TMED2-ALK, a Novel ALK Fusion Gene Identified in a Patient With Lung Adenocarcinoma.
    Mao W, Chen R, Zhang J, Zheng M.
    J Thorac Oncol; 2020 Mar 01; 15(3):e37-e39. PubMed ID: 32093858
    [No Abstract] [Full Text] [Related]

  • 17. A Novel Intergenic Region between CENPA and DPYSL5-ALK Exon 20 Fusion Variant Responding to Crizotinib Treatment in a Patient with Lung Adenocarcinoma.
    Fei X, Zhu L, Zhou H, Qi C, Wang C.
    J Thorac Oncol; 2019 Sep 01; 14(9):e191-e193. PubMed ID: 31445731
    [No Abstract] [Full Text] [Related]

  • 18. Coexistence of a novel RGS18 downstream intergenic region ALK fusion and a THUMPD2-ALK fusion in a lung adenocarcinoma patient and response to crizotinib.
    Wang YL, Wu ZZ, Zhang HR, Chen DS, Zhao X.
    Lung Cancer; 2021 Apr 01; 154():216-218. PubMed ID: 33637344
    [No Abstract] [Full Text] [Related]

  • 19. A novel HIP1-ALK fusion variant in lung adenocarcinoma showing resistance to Crizotinib.
    Li M, Tang Q, Chen S, Wang Y.
    Lung Cancer; 2021 Jan 01; 151():98-100. PubMed ID: 33280926
    [No Abstract] [Full Text] [Related]

  • 20. VPS41-BRAF, a novel BRAF fusion gene identified in a lung adenocarcinoma patient by next-generation sequencing.
    Wang L, Chen A, She X, Xiang J, Tang J.
    Lung Cancer; 2020 Aug 01; 146():380-381. PubMed ID: 32527614
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.